Literature DB >> 7025749

pH-dependent penicillin tolerance of group B streptococci.

D Horne, A Tomasz.   

Abstract

Group B streptococci lose viability without apparent lysis during treatment with beta-lactam antibiotics and vancomycin. Rapid loss of viability was observed in early-exponential-phase cultures. Cultures in the mid-exponential growth phase exhibited various degrees of resistance to the bactericidal effect of the antibiotics, whereas their susceptibilities to the growth-inhibitory effect remained unchanged. This growth-phase-dependent tolerance was caused by the gradual increase in acidity of the cultures as the cell concentration increased. Retitration of the pH to neutrality made the formerly tolerant bacteria again fully susceptible to the killing effect of penicillin. Conversely, lowering the pH value of the medium resulted in antibiotic tolerance throughout culture growth. The penicillin-binding proteins of whole bacteria and their labeling pattern were found to be independent of culture pH. It is suggested that the mechanism of Ph-dependent tolerance is indirect and may be mediated by an autolysin. The tolerance of group B streptococci for penicillin could be clinically relevant in view of the relatively low pH values known to prevail in the natural host environments colonized by these bacteria.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7025749      PMCID: PMC181644          DOI: 10.1128/AAC.20.1.128

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  25 in total

1.  Possible nosocomial transmission of group B streptococci in a newborn nursery.

Authors:  A C Steere; R C Aber; L R Warford; K E Murphy; J C Feeley; P S Hayes; H W Wilkinson; R R Facklam
Journal:  J Pediatr       Date:  1975-11       Impact factor: 4.406

2.  Group B streptococcus in a general hospital.

Authors:  B F Anthony; N F Concepcion
Journal:  J Infect Dis       Date:  1975-11       Impact factor: 5.226

3.  Group B streptococcal neonatal and infant infections.

Authors:  R A Franciosi; J D Knostman; R A Zimmerman
Journal:  J Pediatr       Date:  1973-04       Impact factor: 4.406

4.  Electrophoretic analysis of the major polypeptides of the human erythrocyte membrane.

Authors:  G Fairbanks; T L Steck; D F Wallach
Journal:  Biochemistry       Date:  1971-06-22       Impact factor: 3.162

5.  Suppurative meningitis due to streptococci of Lancefield group B: a study of 33 infants.

Authors:  C J Baker; F F Barrett; R C Gordon; M D Yow
Journal:  J Pediatr       Date:  1973-04       Impact factor: 4.406

6.  A film detection method for tritium-labelled proteins and nucleic acids in polyacrylamide gels.

Authors:  W M Bonner; R A Laskey
Journal:  Eur J Biochem       Date:  1974-07-01

7.  Distinct penicillin binding proteins involved in the division, elongation, and shape of Escherichia coli K12.

Authors:  B G Spratt
Journal:  Proc Natl Acad Sci U S A       Date:  1975-08       Impact factor: 11.205

8.  Maturation of the head of bacteriophage T4. I. DNA packaging events.

Authors:  U K Laemmli; M Favre
Journal:  J Mol Biol       Date:  1973-11-15       Impact factor: 5.469

9.  The role of autolysins in cell death.

Authors:  A Tomasz
Journal:  Ann N Y Acad Sci       Date:  1974-05-10       Impact factor: 5.691

10.  Role of autolysins in the killing of bacteria by some bactericidal antibiotics.

Authors:  H J Rogers; C W Forsberg
Journal:  J Bacteriol       Date:  1971-12       Impact factor: 3.490

View more
  12 in total

1.  A novel mechanism of growth phase-dependent tolerance to isoniazid in mycobacteria.

Authors:  Makoto Niki; Mamiko Niki; Yoshitaka Tateishi; Yuriko Ozeki; Teruo Kirikae; Astrid Lewin; Yusuke Inoue; Makoto Matsumoto; John L Dahl; Hisashi Ogura; Kazuo Kobayashi; Sohkichi Matsumoto
Journal:  J Biol Chem       Date:  2012-05-30       Impact factor: 5.157

2.  Genetic heterogeneity in pbp genes among clinically isolated group B Streptococci with reduced penicillin susceptibility.

Authors:  Noriyuki Nagano; Yukiko Nagano; Kouji Kimura; Kiyoko Tamai; Hideji Yanagisawa; Yoshichika Arakawa
Journal:  Antimicrob Agents Chemother       Date:  2008-09-22       Impact factor: 5.191

3.  Exposure to antibiotics induces expression of the Mycobacterium tuberculosis sigF gene: implications for chemotherapy against mycobacterial persistors.

Authors:  T M Michele; C Ko; W R Bishai
Journal:  Antimicrob Agents Chemother       Date:  1999-02       Impact factor: 5.191

4.  Identification and molecular analysis of PcsB, a protein required for cell wall separation of group B streptococcus.

Authors:  D J Reinscheid; B Gottschalk; A Schubert; B J Eikmanns; G S Chhatwal
Journal:  J Bacteriol       Date:  2001-02       Impact factor: 3.490

5.  Discrepancies between MBC and actual killing of viridans group streptococci by cell-wall-active antibiotics.

Authors:  P R Meylan; P Francioli; M P Glauser
Journal:  Antimicrob Agents Chemother       Date:  1986-03       Impact factor: 5.191

6.  Evaluation of oxacillin tolerance in Staphylococcus aureus by a novel method.

Authors:  B F Woolfrey; R T Lally; M N Ederer
Journal:  Antimicrob Agents Chemother       Date:  1985-09       Impact factor: 5.191

7.  Reverse inoculum effect in bactericidal activity and other variables affecting killing of group B streptococci by penicillin.

Authors:  L Jokipii; P Brander; A M Jokipii
Journal:  Antimicrob Agents Chemother       Date:  1985-06       Impact factor: 5.191

8.  Antibiotic resistance patterns of group B streptococci in pregnant women.

Authors:  K Berkowitz; J A Regan; E Greenberg
Journal:  J Clin Microbiol       Date:  1990-01       Impact factor: 5.948

9.  pH-dependent penicillin tolerance may protect intraleukocytic Staphylococcus aureus from killing by cloxacillin.

Authors:  N Craven; J C Anderson
Journal:  Antimicrob Agents Chemother       Date:  1982-04       Impact factor: 5.191

10.  Penicillin tolerance in nutritionally variant streptococci.

Authors:  Y Holloway; J Dankert
Journal:  Antimicrob Agents Chemother       Date:  1982-12       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.